An Integrative Analysis of Transcriptome and Epigenome Features of ASCL1–Positive Lung Adenocarcinomas-Reference-Cited by-同舟云学术

An Integrative Analysis of Transcriptome and Epigenome Features of ASCL1–Positive Lung Adenocarcinomas

Published:2018-11 Issue:11 Volume:13 Page:1676-1691
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Miyashita Naoya,Horie Masafumi,Suzuki Hiroshi I.,Yoshihara Masahito,Djureinovic Dijana,Persson Johan,Brunnström Hans,Lindskog Cecilia,Elfving Hedvig,Micke Patrick,Saito Akira,Nagase Takahide

Funder

Takeda Science Foundation

JSPS KAKENHI

Uehara Memorial Foundation Research Fellowship

RIKEN Junior Research Associate program

Osamu Hayaishi Memorial Scholarship

Knut and Alice Wallenberg Foundation

Swedish Cancer Society and Lions Cancer Foundation, Uppsala, Sweden

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference53 articles.

1. Lung cancer;Herbst;N Engl J Med,2008

2. Comprehensive genomic characterization of squamous cell lung cancers;Nature,2012

3. Comprehensive molecular profiling of lung adenocarcinoma;Nature,2014

4. Integrative CAGE and DNA methylation profiling identify epigenetically regulated genes in NSCLC;Horie;Mol Cancer Res,2017

5. Gene expression profiling of large cell lung cancer links transcriptional phenotypes to the new histological WHO 2015 Classification;Karlsson;J Thorac Oncol,2017

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenic role of super-enhancers as potential therapeutic targets in lung cancer;Frontiers in Pharmacology;2024-04-12

2. Multifaced roles of the long non-coding RNA DRAIC in cancer progression;Life Sciences;2024-04

3. Chromogenic in situ hybridization reveals specific expression pattern of long non-coding RNA DRAIC in formalin-fixed paraffin-embedded specimen;Non-coding RNA Research;2024-03

4. Distinct microRNA Signature and Suppression of ZFP36L1 Define ASCL1-Positive Lung Adenocarcinoma;Molecular Cancer Research;2023-10-06

5. An integrative epigenomic approach identifies ELF3 as an oncogenic regulator in ASCL1‐positive neuroendocrine carcinoma;Cancer Science;2023-03-15